Professor Vijay Chandru (PhD, MIT) represents the convergence of academic excellence, entrepreneurial success, and public policy impact that defines HSG's approach to technology-driven strategic advisory. As an elected Fellow of the American Association for the Advancement of Science (2023), Indian Academy of Sciences (1996), and Indian National Academy of Engineering (2010), he brings world-class expertise in computational sciences, biotechnology innovation, and digital health systems.

​

His entrepreneurial journey includes founding and leading Strand Life Sciences (2000-2018), India's leading precision medicine company, and co-founding CRISPRBITS for point-of-care diagnostics. As President of ABLE (Association of Biotechnology Led Enterprises) from 2009-2012, he shaped India's biotechnology policy landscape. Currently serving as Chair of the Advisory Committee for the National One Health Mission under the Principal Scientific Advisor to the Government of India, he continues to influence national technology policy at the highest levels.

​

Professor Chandru's expertise directly addresses HSG's focus areas of health technology and digital health policy, innovation ecosystems and technology transfer, and biotechnology trade policies. His current roles span prestigious institutions: Visiting Scientist at Harvard School of Public Health, Visiting Professor at multiple premier institutions including NCBS-TIFR, and Executive Advisor to the AI & Robotics Technology Park at IISc.

​

His co-chairmanship of the Technology Workstream for the Lancet Citizens Commission on Reimagining India's Health Systems, combined with his Technology Pioneer recognition from the World Economic Forum (2006), positions him to guide HSG's clients through the complex landscape of health technology policy, public-private partnerships, and innovation commercialization pathways. His academic-industry-government nexus experience is invaluable for HSG's mission to bridge policy and technology implementation.